Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (5) Luft, Friedrich Prof. Dr. (1) Niendorf, Thoralf Prof. Dr. (12) Uckert, Wolfgang Prof. Dr. (1) Waiczies, Helmar Dr. (1) Waiczies, Sonia PD Dr. (1) Wolf, Jana Prof. Dr. (3) (-) Rehm, Armin Dr. (7) 2001 (1) (-) 2002 (2) 2003 (1) (-) 2004 (1) (-) 2005 (3) 2007 (3) 2008 (1) (-) 2009 (3) 2012 (4) 2014 (4) 2015 (10) 2017 (10) 2018 (7) 2019 (7) 2020 (13) 2021 (26) 2022 (8) 2023 (1) 2024 (2) (-) Experimental Ultrahigh-Field MR (2) Magnetic Resonance (2) (-) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (6) Mobile DNA (1) Molecular Cardiovascular Research (1) Molecular Pathways in Cortical Development (1) (-) Translational Tumorimmunology (6) 9 Results: Active Filter: Rehm, Armin Dr.Experimental Ultrahigh-Field MRMathematical Modelling of Cellular ProcessesTranslational Tumorimmunology2002200420052009 Sort: Result score Newest to oldest Oldest to newest September 10, 2004 / Biochem Biophys Res Commun HCMV-encoded chemokine receptor US28 employs multiple routes for internalization J. Droese T. Mokros R. Hermosilla R. Schuelein M. Lipp U.E. Höpken A. Rehm January 05, 2005 / Mol Biol Cell EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin C. Rueder T. Reimer I. Delgado-Martinez R. Hermosilla A. Engelsberg R. Nehring B. Doerken A. Rehm September 23, 2005 / Eur J Immunol The ratio between dendritic cells and T cells determines the outcome of their encounter: Proliferation versus deletion U.E. Höpken I. Lehmann J. Droese M. Lipp T. Schueler A. Rehm May 01, 2002 / J Virol Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells A. Rehm A. Engelsberg D. Tortorella I.J. Körner I. Lehmann H.L. Ploegh U.E. Höpken August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm January 01, 2002 / J Biol Chem Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by agonist-independent phosphorylation T. Mokros A. Rehm J. Droese M. Oppermann M. Lipp U.E. Höpken January 01, 2005 / BMC Cancer Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker T.A. Reimer I. Anagnostopoulos B. Erdmann I. Lehmann H. Stein P. Daniel B. Doerken A. Rehm May 13, 2009 / Brain Res Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI S. Maheswaran H. Barjat D. Rueckert S.T. Bate D.R. Howlett L. Tilling S.C. Smart A. Pohlmann J.C. Richardson T. Hartkens D.L.G. Hill N. Upton J.V. Hajnal M.F. James April 01, 2009 / Inflamm Bowel Dis Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI A. Pohlmann L.C. Tilling A. Robinson O. Woolmer S. McCleary L. Kruidenier L.C. Warnock H.D. Lewis A.R. Hobson M.F. James
September 10, 2004 / Biochem Biophys Res Commun HCMV-encoded chemokine receptor US28 employs multiple routes for internalization J. Droese T. Mokros R. Hermosilla R. Schuelein M. Lipp U.E. Höpken A. Rehm
January 05, 2005 / Mol Biol Cell EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin C. Rueder T. Reimer I. Delgado-Martinez R. Hermosilla A. Engelsberg R. Nehring B. Doerken A. Rehm
September 23, 2005 / Eur J Immunol The ratio between dendritic cells and T cells determines the outcome of their encounter: Proliferation versus deletion U.E. Höpken I. Lehmann J. Droese M. Lipp T. Schueler A. Rehm
May 01, 2002 / J Virol Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells A. Rehm A. Engelsberg D. Tortorella I.J. Körner I. Lehmann H.L. Ploegh U.E. Höpken
August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm
January 01, 2002 / J Biol Chem Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by agonist-independent phosphorylation T. Mokros A. Rehm J. Droese M. Oppermann M. Lipp U.E. Höpken
January 01, 2005 / BMC Cancer Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker T.A. Reimer I. Anagnostopoulos B. Erdmann I. Lehmann H. Stein P. Daniel B. Doerken A. Rehm
May 13, 2009 / Brain Res Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI S. Maheswaran H. Barjat D. Rueckert S.T. Bate D.R. Howlett L. Tilling S.C. Smart A. Pohlmann J.C. Richardson T. Hartkens D.L.G. Hill N. Upton J.V. Hajnal M.F. James
April 01, 2009 / Inflamm Bowel Dis Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI A. Pohlmann L.C. Tilling A. Robinson O. Woolmer S. McCleary L. Kruidenier L.C. Warnock H.D. Lewis A.R. Hobson M.F. James